Literature DB >> 9531299

Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.

A Wright1, S L Morrison.   

Abstract

The complex biantennary oligosaccharide at Asn297 of IgG is essential for some effector functions. To investigate the effect of carbohydrate structure on Ab function, we have now expressed mouse-human chimeric IgG1 Abs in Chinese hamster ovary (CHO) cells with defined defects in carbohydrate biosynthesis. We had previously shown that IgG1 Abs produced in the cell line Lec 1, which attaches a high-mannose intermediate carbohydrate, were severely deficient in complement activation, showed a slightly reduced affinity for Fc gammaRI, and had a reduced in vivo half-life. We have extended these studies by producing the same dansyl-specific IgG1 in cell lines deficient in attachment of sialic acid (Lec 2) and galactose (Lec 8). IgG1-Lec 1, IgG1-Lec 2, and IgG1-Lec 8 all showed varying reactivity with a mAb specific for an epitope in the amino terminal region of C(H)2, suggesting that the conformations of these proteins were altered by the different carbohydrate structures. Functionally, IgG1-Lec 2 and IgG1-Lec 8 were comparable to wild type with respect to in vivo half-life, affinity for Fc gammaRI, and capacity for complement-mediated hemolysis. While IgG1-Lec 2 was essentially identical to wild type in its capacity to interact with individual components of the classical complement activation pathway, IgG1-Lec 8 demonstrated equivalent maximal binding at lower concentrations and was preferentially bound by mannose-binding protein. Although IgG1-Lec 1 was deficient in activation of the classical pathway, it had a superior capacity to activate the alternative pathway. These studies demonstrate that Abs bearing C(H)2-linked carbohydrate of differing structures have different functional properties.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9531299

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

Review 1.  Engineered CD3 antibodies for immunosuppression.

Authors:  L Renders; T Valerius
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

2.  Characterization of the basic charge variants of a human IgG1: effect of copper concentration in cell culture media.

Authors:  Timothy Kaschak; Daniel Boyd; Franklin Lu; Gayle Derfus; Brian Kluck; Bartek Nogal; Craig Emery; Christie Summers; Kai Zheng; Robert Bayer; Ashraf Amanullah; Boxu Yan
Journal:  MAbs       Date:  2011-11-01       Impact factor: 5.857

Review 3.  Lepidopteran cells, an alternative for the production of recombinant antibodies?

Authors:  Martine Cérutti; Josée Golay
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

Review 4.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

5.  Glycan structure and serum half-life of recombinant CTLA4Ig, an immunosuppressive agent, expressed in suspension-cultured rice cells with coexpression of human β1,4-galactosyltransferase and human CTLA4Ig.

Authors:  Seung Hoon Kang; Hahn Sun Jung; Song Jae Lee; Cheon Ik Park; Sang Min Lim; Heajin Park; Byung Sun Kim; Kwang Heum Na; Gyeong Jin Han; Jae Woo Bae; Hyun Joo Park; Keuk Chan Bang; Byung Tae Park; Hye Seong Hwang; In-Soo Jung; Jae Il Kim; Doo Byung Oh; Dong Il Kim; Hirokazu Yagi; Koichi Kato; Dae Kyong Kim; Ha Hyung Kim
Journal:  Glycoconj J       Date:  2015-05-14       Impact factor: 2.916

6.  Plant species and organ influence the structure and subcellular localization of recombinant glycoproteins.

Authors:  Elsa Arcalis; Johannes Stadlmann; Thomas Rademacher; Sylvain Marcel; Markus Sack; Friedrich Altmann; Eva Stoger
Journal:  Plant Mol Biol       Date:  2013-04-04       Impact factor: 4.076

Review 7.  Analytical comparability study of recombinant monoclonal antibody therapeutics.

Authors:  Alexandre Ambrogelly; Stephen Gozo; Amit Katiyar; Shara Dellatore; Yune Kune; Ram Bhat; Joanne Sun; Ning Li; Dongdong Wang; Christine Nowak; Alyssa Neill; Gomathinayagam Ponniah; Cory King; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-03-20       Impact factor: 5.857

8.  Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in rats.

Authors:  Leslie A Khawli; Sirj Goswami; Ryan Hutchinson; Zephania W Kwong; Jihong Yang; Xiangdan Wang; Zhenling Yao; Alavattam Sreedhara; Tony Cano; Devin Tesar; Ihsan Nijem; David E Allison; Pin Yee Wong; Yung-Hsiang Kao; Cynthia Quan; Amita Joshi; Reed J Harris; Paul Motchnik
Journal:  MAbs       Date:  2010-11-01       Impact factor: 5.857

9.  B lymphocyte galactosyltransferase protein levels in normal individuals and in patients with rheumatoid arthritis.

Authors:  J Keusch; P M Lydyard; E G Berger; P J Delves
Journal:  Glycoconj J       Date:  1998-11       Impact factor: 2.916

10.  Optimized expression of full-length IgG1 antibody in a common E. coli strain.

Authors:  Conrad En Zuo Chan; Angeline Pei Chiew Lim; Annie Hoi Yi Chan; Paul A MacAry; Brendon John Hanson
Journal:  PLoS One       Date:  2010-04-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.